The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This was interesting from March 2023,also on Friday a large trade 700,000 shares was disclosed,and after that the share price started rising
Commenting on MGC Pharma's update, Victor Bolduev, CEO, commented:
'This is a major milestone for MGC Pharma and the NDC listing for over-the-counter sales of ArtemiC™ provides significant access to the largest healthcare market in the world. The order from their US based distribution partner, AMC, endorses the importance of the ArtemiC™ product, and with GraftBio's® drug delivery platform plating a crucial role it its manufacture, I am very encouraged about the potential of, and future uses of, our technology going forward.'
Looks like it will starting rising
Cash £1.64mln plus
- Net cash inflow for the period was £1.057 million
- The Group held net assets at Period end of £4.554 million
Davey, ‘ do not know this stock’ from the distinct lack of chat and trades I would say very few know much about this stock,
With regard your sell order comment, I too find it odd that dummy trades were going NT half of the time and as yourself and Laura just said, only small amounts were offered when not NT which is at odds with the ‘sell order’ theory,
I also note GPL are not on the ‘share fallers’ board on this site until you click into ‘more share fallers’ a glitch I have noted before with other stocks.
See what tomorrow brings eh
GLA
F
Hi davey
Since 11.00am it was either not able to buy or £1000 maximum
CEO hold 29%
I do not know this stock but clearly Peel are working a sell order. But strange they would not let buy several times today when I tried. See what happens in the morning
Won first revenue generating commercial order for 50,000 units of MGC Pharmaceuticals product, ArtemiC™ Rescue on 18 August 2022, which uses the Company's GraftBio proprietary drug delivery system
- December 2022 saw the Group's strongest month of sales in the year which followed month-on-month sales growth in 2022. The pipeline for 2023 is looking healthy as the Company looks to capitalise on the enlargement of its operations with larger mandates
Looks cheap
£4mln assets + £1.5mln cash
Market overreacted to very Conservative auditors comment ( all quditors being super cautious this last 12mths )
Directors say going concern in fine
Someone bought a quids worth last Thursday….
No wonder the price is dropping Peel keep dropping lower and lower and not letting anybody buy. I keep sending down fill or kills nothing fancy 25k's and they refuse the lot, pointless buying the 5000 NMS
Troajan
Since your last post
See where the share price is
Polymer for car and particularly medical applications. More than dozen other lesser markets too. More than 50 unique products. Some products recyclable. More of an additive business which can produce unique products unlike competitors.
Why?
Give this one a wide berth people don’t get sucked in